论文部分内容阅读
近日,国务院印发“十三五”深化医药卫生体制改革规划(以下简称规划)。规划要求,到2020年,形成1家年销售额超过5 000亿元的超大型药品流通企业,还将对各级各类医疗卫生机构监督检查实现100%覆盖。
Recently, the State Council issued the “Thirteen Five-Year Plan” to deepen the reform of the medical and health system (hereinafter referred to as the plan). According to the plan, a super-large pharmaceutical distribution enterprise with annual sales of more than 500 billion yuan will be formed by 2020 and a 100% coverage will also be given to the supervision and inspection of all kinds of medical and health institutions at all levels.